Home / Inspections / 1088154

FDA Inspection 1088154 — Bioreliance Ltd.

Bioreliance Ltd. — FEI 3005619549

The FDA completed an inspection of Bioreliance Ltd. on March 21, 2019 in Stirling, Scotland. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 21, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Stirling, Scotland (United Kingdom)

Facility

Other inspections at this facility

  • 1223799 (NAI Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1202973 (VAI Thu Jun 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1066803 (VAI Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976603 (VAI Thu Mar 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 890477 (NAI Fri Jul 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources